Real-World Application of HER2-Targeted Therapies: Case-Based Insights

This section provides practical insights that help oncologists bridge the gap between evidence and practice, enhancing the applicability of HER2-targeted therapies in diverse patient populations.

A discussion of real-world application of HER2-targeted therapies, incorporating case-based insights to illustrate clinical decision-making. Drs. Santos and Lopes discuss how trial data translate into everyday practice, highlighting nuances that may not be fully captured in clinical studies.

Key considerations include patient comorbidities, performance status, prior treatments, and access to therapies. The speakers emphasize that while clinical trial data provides a foundation, real-world factors often influence treatment selection and sequencing.

The discussion also addresses the importance of shared decision-making, ensuring that patients are informed about the risks and benefits of different treatment options. This is particularly relevant given the unique toxicity profiles of ADCs and the need for close monitoring.

The segment underscores the gap between clinical trial populations and real-world patients, highlighting the need for individualized care.